{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:16Z","timestamp":1793321056264,"version":"4.5.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,1,23]]},"abstract":"<jats:sec id=\"ab-joi230156-4\"><jats:title>Importance<\/jats:title><jats:p>Adverse outcomes associated with treatments for localized prostate cancer remain unclear.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-5\"><jats:title>Objective<\/jats:title><jats:p>To compare rates of adverse functional outcomes between specific treatments for localized prostate cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>An observational cohort study using data from 5 US Surveillance, Epidemiology, and End Results Program registries. Participants were treated for localized prostate cancer between 2011 and 2012. At baseline, 1877 had favorable-prognosis prostate cancer (defined as cT1-cT2bN0M0, prostate-specific antigen level &amp;amp;lt;20 ng\/mL, and grade group 1-2) and 568 had unfavorable-prognosis prostate cancer (defined as cT2cN0M0, prostate-specific antigen level of 20-50 ng\/mL, or grade group 3-5). Follow-up data were collected by questionnaire through February 1, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-7\"><jats:title>Exposures<\/jats:title><jats:p>Radical prostatectomy (n\u2009=\u20091043), external beam radiotherapy (n\u2009=\u2009359), brachytherapy (n\u2009=\u200996), or active surveillance (n\u2009=\u2009379) for favorable-prognosis disease and radical prostatectomy (n\u2009=\u2009362) or external beam radiotherapy with androgen deprivation therapy (n\u2009=\u2009206) for unfavorable-prognosis disease.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Outcomes were patient-reported sexual, urinary, bowel, and hormone function measured using the 26-item Expanded Prostate Cancer Index Composite (range, 0-100; 100\u2009=\u2009best). Associations of specific therapies with each outcome were estimated and compared at 10 years after treatment, adjusting for corresponding baseline scores, and patient and tumor characteristics. Minimum clinically important differences were 10 to 12 for sexual function, 6 to 9 for urinary incontinence, 5 to 7 for urinary irritation, and 4 to 6 for bowel and hormone function.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-9\"><jats:title>Results<\/jats:title><jats:p>A total of 2445 patients with localized prostate cancer (median age, 64 years; 14% Black, 8% Hispanic) were included and followed up for a median of 9.5 years. Among 1877 patients with favorable prognosis, radical prostatectomy was associated with worse urinary incontinence (adjusted mean difference, \u221212.1 [95% CI, \u221216.2 to \u22128.0]), but not worse sexual function (adjusted mean difference, \u22127.2 [95% CI, \u221212.3 to \u22122.0]), compared with active surveillance. Among 568 patients with unfavorable prognosis, radical prostatectomy was associated with worse urinary incontinence (adjusted mean difference, \u221226.6 [95% CI, \u221235.0 to \u221218.2]), but not worse sexual function (adjusted mean difference, \u22121.4 [95% CI, \u221211.1 to 8.3), compared with external beam radiotherapy with androgen deprivation therapy. Among patients with unfavorable prognosis, external beam radiotherapy with androgen deprivation therapy was associated with worse bowel (adjusted mean difference, \u22124.9 [95% CI, \u22129.2 to \u22120.7]) and hormone (adjusted mean difference, \u22124.9 [95% CI, \u22129.5 to \u22120.3]) function compared with radical prostatectomy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-joi230156-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Among patients treated for localized prostate cancer, radical prostatectomy was associated with worse urinary incontinence but not worse sexual function at 10-year follow-up compared with radiotherapy or surveillance among people with more favorable prognosis and compared with radiotherapy for those with unfavorable prognosis. Among men with unfavorable-prognosis disease, external beam radiotherapy with androgen deprivation therapy was associated with worse bowel and hormone function at 10-year follow-up compared with radical prostatectomy.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jama.2023.26491","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T16:08:30Z","timestamp":1706026110000},"page":"302","source":"Crossref","is-referenced-by-count":110,"title":["Functional Outcomes After Localized Prostate Cancer Treatment"],"prefix":"10.1001","volume":"331","author":[{"given":"Bashir","family":"Al Hussein Al Awamlh","sequence":"first","affiliation":[{"name":"Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J. D.","family":"Wallis","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Penson","sequence":"additional","affiliation":[{"name":"Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Veterans Affairs Tennessee Valley Geriatric Research Education and Clinical Center, Nashville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ching","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Conwill","sequence":"additional","affiliation":[{"name":"Office of Patient and Community Education, Patient Advocacy Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Talwar","sequence":"additional","affiliation":[{"name":"Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Morgans","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goodman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine at the University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Cheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Louisiana State University New Orleans School of Public Health, New Orleans"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Paddock","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Services, New Jersey Department of Health, Rutgers Cancer Institute of New Jersey, New Brunswick"},{"name":"Rutgers School of Public Health, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Stroup","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Services, New Jersey Department of Health, Rutgers Cancer Institute of New Jersey, New Brunswick"},{"name":"Rutgers School of Public Health, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock B.","family":"O\u2019Neil","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Utah Health, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Texas MD Anderson Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Barocas","sequence":"additional","affiliation":[{"name":"Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"joi230156r1","first-page":"1288","article-title":"NCCN Guidelines Insights: Prostate Cancer, Version 1.2023.","volume":"20","author":"Schaeffer","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"17","key":"joi230156r2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer.","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"joi230156r3","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years.","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"joi230156r4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer.","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"joi230156r5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer.","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"joi230156r6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer.","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"key":"joi230156r7","doi-asserted-by":"publisher","first-page":"m3503","DOI":"10.1136\/bmj.m3503","article-title":"Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.","volume":"371","author":"Mazariego","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"joi230156r8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors.","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"joi230156r9","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300018","article-title":"Patient-reported outcomes 12 years after localized prostate cancer treatment.","volume":"2","author":"Donovan","year":"2023","journal-title":"NEJM Evid"},{"issue":"4","key":"joi230156r10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2217\/cer.13.34","article-title":"Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.","volume":"2","author":"Barocas","year":"2013","journal-title":"J Comp Eff Res"},{"issue":"10","key":"joi230156r11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41416-018-0071-4","article-title":"The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.","volume":"118","author":"Wallis","year":"2018","journal-title":"Br J Cancer"},{"issue":"1","key":"joi230156r12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management.","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"5","key":"joi230156r13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"issue":"5","key":"joi230156r14","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/hesr.2012.47.issue-5","article-title":"Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.","volume":"47","author":"Jayadevappa","year":"2012","journal-title":"Health Serv Res"},{"issue":"1","key":"joi230156r15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"issue":"3","key":"joi230156r16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"issue":"9","key":"joi230156r17","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/cncr.v109:9","article-title":"Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.","volume":"109","author":"Litwin","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"joi230156r18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey.","volume":"32","author":"Sherbourne","year":"1991","journal-title":"Soc Sci Med"},{"issue":"2","key":"joi230156r19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","article-title":"Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).","volume":"10","author":"Andresen","year":"1994","journal-title":"Am J Prev Med"},{"issue":"5","key":"joi230156r20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7326\/0003-4819-124-5-199603010-00007","article-title":"Characteristics of physicians with participatory decision-making styles.","volume":"124","author":"Kaplan","year":"1996","journal-title":"Ann Intern Med"},{"issue":"3","key":"joi230156r21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II, psychometric and clinical tests of validity in measuring physical and mental health constructs.","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"issue":"4","key":"joi230156r23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.v30.4","article-title":"Multiple imputation using chained equations: issues and guidance for practice.","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"issue":"1","key":"joi230156r24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening.","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"issue":"7","key":"joi230156r25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jnci\/djac066","article-title":"Grade migration of prostate cancer in the United States during the last decade.","volume":"114","author":"Borregales","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"joi230156r26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis.","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"joi230156r27","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1001\/jamainternmed.2022.7100","article-title":"Use of active surveillance vs definitive treatment among men with low- and favorable intermediate-risk prostate cancer in the US between 2010 and 2018.","volume":"183","author":"Al Hussein Al Awamlh","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"5","key":"joi230156r28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.eururo.2017.04.029","article-title":"A pragmatic randomized controlled trial examining the impact of the retzius-sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy.","volume":"72","author":"Dalela","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"joi230156r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.8221","article-title":"Association of the placement of a perirectal hydrogel spacer with the clinical outcomes of men receiving radiotherapy for prostate cancer: a systematic review and meta-analysis.","volume":"3","author":"Miller","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"15","key":"joi230156r30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer.","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"joi230156r22","doi-asserted-by":"crossref","DOI":"10.1201\/9781439821862","volume-title":"Analysis of Incomplete Multivariate Data","author":"Schafer","year":"1997"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2814131\/jama_al_hussein_al_awamlh_2024_oi_230156_1705010834.66513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T16:08:34Z","timestamp":1706026114000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2814131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,1,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.26491","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}